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Activation and recruitment of thermogenic cells in
human white adipose tissues (‘‘browning’’) can
counteract obesity and associated metabolic disor-
ders. However, quantifying the effects of therapeutic
interventions on browning remains enigmatic. Here,
we devise a computational tool, named ProFAT
(profiling of fat tissue types), for quantifying the ther-
mogenic potential of heterogeneous fat biopsies
based on prediction of white and brown adipocyte
content from raw gene expression datasets. ProFAT
systematically integrates 103 mouse-fat-derived
transcriptomes to identify unbiased and robust
gene signatures of brown and white adipocytes.
We validate ProFAT on 80mouse and 97 human tran-
scriptional profiles from 14 independent studies and
correctly predict browning capacity upon various
physiological and pharmacological stimuli. Our study
represents the most exhaustive comparative anal-
ysis of public data on adipose biology toward quan-
tification of browning after personalized medical
intervention. ProFAT is freely available and should
become increasingly powerful with the growing
wealth of transcriptomics data.
INTRODUCTION
Adipose tissue is broadly divided into white and brown, based on
key anatomic, structural, molecular, and metabolic differences
(Frontini and Cinti, 2010). White adipose tissue (WAT) is special-
ized to store chemical energy as fat, whereas brown adipose tis-
sue (BAT) can catabolize lipids and glucose for non-shivering
thermogenesis, due to the high mitochondrial mass and expres-
sion of uncoupling protein 1 (UCP1), a mitochondrial inner mem-
brane protein that dissipates energy from substrate oxidation
directly as heat.3112 Cell Reports 23, 3112–3125, June 5, 2018 ª 2018 The Author(s
This is an open access article under the CC BY-NC-ND license (http://Although major WAT and BAT depots are located in anatomi-
cally distinct regions, brown-like, UCP1-positive fat cells can be
found sporadically and interspersed in various WAT depots in
response to cold exposure or b-adrenergic receptor agonists.
These cells have been termed beige, brite (brown-in-white), re-
cruitable or inducible brown, or brown-like adipocytes (Ishibashi
and Seale, 2010), owing to their morphological and metabolic
features that are similar to ‘‘classical’’ brown adipocytes and to
the expression of thermogenic genes (Shabalina et al., 2013).
Several studies have suggested that beige adipocytes can
derive from bipotential WAT precursors and mature white adipo-
cytes (Barbatelli et al., 2010; Himms-Hagen et al., 2000; Schulz
et al., 2011; Wang et al., 2013). However, the structural and func-
tional differences that distinguish them from BAT and WAT still
remain unclear.
Advance in positron emission tomography (PET) scanning
methods have allowed the discovery that adult humans contain
significant deposits of UCP1-positive brown cells in the supra-
clavicular and neck region (Farmer, 2009) as well as in multiple
human WAT depots upon exposure to various physiological
and pharmacological effectors (Cypess et al., 2013; Jespersen
et al., 2013; Lidell et al., 2013). Promoting the appearance of
thermogenic cells in non-classical BAT locations can increase
energy expenditure and substrate metabolism, improve glucose
tolerance, and correct hyperlipidemia, leading to a healthier
metabolic phenotype in both rodents (Bartelt et al., 2011; Min
et al., 2016; Stanford et al., 2013) and humans (Saito et al.,
2009). Quantifying the browning potential of therapeutic inter-
ventions on human BAT activation would therefore accelerate
the identification of therapeutic avenues to reduce obesity and
its comorbidities. However, this remains challenging, given that
human fat contains only a small fraction of brown and brown-
like adipocytes.
Lineage-tracing studies for the selective isolation of different
adipose cell types have been performed in mice (Bartelt and
Heeren, 2014) but are not possible in humans. Furthermore,
currently available imaging methods have a limited sensitivity,
and the resulting data are difficult to deconvolute. Besides, there
are only a handful of adipose tissue marker genes, which have).
creativecommons.org/licenses/by-nc-nd/4.0/).
only been used so far to make a qualitative distinction between
human adipocytes or adipose tissue types. Those markers orig-
inate from either analyses of whole adipose tissue depots, con-
taining a great proportion of contaminating cells, or ex vivo stable
and clonally derived adipocytes (Cypess et al., 2013; Shinoda
et al., 2015; Wu et al., 2012), which are affected by in vitro cell
culture conditions. Therefore, novel approaches for the unbiased
quantification of browning capacity in patients’ fat depots are
required.
Here, we take advantage of the wealth of data on global tran-
scriptional profiling of fat depots published over the last decade
to develop a robust and automated computational pipeline,
which we call ProFAT (profiling of fat tissue types), for the sys-
tematic prediction of mouse and human adipose browning ca-
pacity based on raw gene expression data (Figure 1). First, we
identify a molecular signature of brown and white adipocytes
by integrating 51 and 52 global transcriptional profiles of mouse
BAT and WAT from seven independent studies, respectively.
Next, we develop a computational model trained on all 103 da-
tasets and show that it can correctly classify over 80 additional
mouse BAT and WAT samples from nine published studies.
Importantly, the model can estimate the degree of browning
for WAT-treated samples (beige) independently from biological
and technical differences in the anatomical location of fat
depots and in experimental models and procedures. We
also confirm that our model can be applied to humans and
predict the browning capacity of 96 samples derived from
heterogeneous tissue biopsies and ex vivo immortalized adipo-
cytes. ProFAT is freely available (http://profat.genzentrum.
lmu.de) and allows users to automatically perform hierarchical
clustering (HC), principal-component analysis (PCA), and pre-
diction of browning capacity from raw microarray and RNA
sequencing (RNA-seq) datasets.
RESULTS
A Comprehensive Mouse-Adipocyte-Centered Gene
Expression Atlas
To compile a comprehensive and unbiased gene expression
atlas of mouse fat, we systematically retrieved whole-genome
transcriptomes from microarray and RNA-seq studies on adi-
pose tissue biopsies and differentiated clonal adipocytes that
are publicly available in GEO and ArrayExpress databases. A
total of 16 independent studies on at least two clearly defined
adipocytes, for example, classical brown, white, and inducible
brown adipocytes (beige or brite), were selected for down-
stream computational analyses (Baboota et al., 2015; Fang
et al., 2015; Fitzgibbons et al., 2011; Grimaldi et al., 2010;
Long et al., 2014; Majka et al., 2010; Ohno et al., 2012; Rosell
et al., 2014; Seale et al., 2007; Sharp et al., 2012; Su et al.,
2004; Timmons et al., 2007; Wang et al., 2016; Wu et al.,
2012; Xue et al., 2009; Zhang et al., 2014; Table S1; Figure 2A).
Those included 174 microarray and 34 RNA-seq datasets of
high reads quality and correlation between biological replicates
(Figures S1 and S2), of which 83 were gene expression data-
sets on a variety of white fat depots originating from different
anatomical locations, such as epididymal, inguinal, gonadal,
perivascular, mesenteric, and subcutaneous WAT (Figure 2B).In addition, it contains 63 gene expression datasets on inter-
scapular BAT and 52 on beige or brite adipocytes originated
from different WAT depots in response to treatments such as
cold, PPAR-gamma agonists (rosiglitazone, fexaramine, forsko-
lin, and roscovitine), and beta-3 adrenergic receptor agonists
(CL316,243; Figures 2A and 2B).
Gene Expression Signatures of Brown, White, and Beige
or Brite Fat
To construct a global adipose-tissue-centered gene expression
map, we aggregated transcriptional profiles from all microarray
or RNA-seq-based studies in our atlas (Figure 1). First, spurious
differences in gene expression between studies, due to technical
variation in array platforms and sequencing libraries, were
resolved by correcting for batch effects. Next, PCA (Figure 2C)
and HC (Figures S3 and S4) were applied to evaluate the related-
ness between transcriptional profiles of BAT, WAT, and beige or
brite-depots-derived datasets from all studies. Both approaches
highlighted a strong and robust gene expression signature from
BAT- and WAT-derived samples, despite their heterogeneous
composition. On the whole-genome transcriptional level, the
variation between WAT depots, due for example to different
anatomical regions, proportion of distinct adipocytes, age,
food, and gender, had no relevant contribution to the global
WAT signature. Furthermore, the gene expression signatures
of BAT and WAT were always clearly distinct, independently
from the sequencing method (microarray versus RNA-seq), re-
flecting robust transcriptional differences in the regulation of
their physiology and metabolism. Surprisingly, perivascular
WAT (pvWAT) samples from study M9 (Fitzgibbons et al., 2011)
showed a molecular signature indistinguishable from BAT-
derived samples. This result is fully consistent with findings by
Fitzgibbons et al. that thoracic pvWAT from mice fed either a
normal or high-fat diet has virtually identical gene expression
profiles to brown adipocytes.
With the exception of samples from Wang et al. (2016) (study
M13), the transcriptional profile of beige or brite adipocytes
from other studies was not clearly distinct from either WAT or
BAT groups in both PCA and HC analyses (Figures 2C, S3, and
S4). For example, gene expression profiles of beige or brite sam-
ples from inguinal WAT (iWAT) biopsies of C57BL6 male mice
kept in cold for 1–5 weeks (study M8; Xue et al., 2009) were
similar to that of BAT samples in the atlas, grouping together in
both PCA and HC analyses. On the contrary, beige or brite sam-
ples from subcutaneous (sWAT) and mesenteric (mWAT) WAT
biopsies of SV129 female mice kept in cold for 10 days (study
M10; Rosell et al., 2014) showed a gene expression signature
similar to WAT samples from the same as well as from other
studies. Similarly, beige or brite adipocytes from cold acclimated
(study R1; Long et al., 2014) and fexaramine-stimulated (study
R2) iWAT and gonadal WAT (gWAT) (Fang et al., 2015) clustered
with WAT samples from other RNA-seq studies in the atlas,
whereas beige or brite adipocytes from iWAT treated with rosigli-
tazone (study R3; Sharp et al., 2012) grouped with BAT samples.
Taken together, our systematic analysis of transcriptomics
data from many published studies highlights robust gene
expression differences between BAT andWAT that are indepen-
dent of experimental procedures, sample purity, origin of fatCell Reports 23, 3112–3125, June 5, 2018 3113
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depots, and sequencing methods and can therefore be used to
predict an unbiased molecular signature of BAT and WAT.
Prediction of BAT and WAT Molecular Signatures
As a first step toward the prediction of brown adipocytes content
(browning capacity) in whole adipose tissue depots, we identi-
fied marker genes for classical brown and white fat tissue classi-
fication (Figure 3). To this goal, we integrated 51 BAT and 52
WAT transcriptional profiles from seven out of 16 independent
studies in our atlas (M1, M2, M4, M5, M6, M7, and M12 and
R4 in Figure 2A). Data normalization and batch effect removal
were performed to ensure that differences in gene expression in-
tensities were indeed due to differential expression betweenBAT
and WAT sample groups. Ideally, brown and white fat-specific
markers should show an ‘‘absolute’’ difference in expression to
allow a clear distinction between BAT and WAT, independently
of biological differences in fat depots, sample composition
(pure populations versus whole tissue biopsies), and their
expression in other cell types. Overall, we found a total of 59
genes (Figure 3A) that were consistently and significantly differ-
entially expressed between all BAT and WAT samples (log2 fold
change > 1.5 and p-adj value < 0.01). We identified several
known brown fat markers, such as Ucp1, Cidea (cell death-
inducing DFFA-like effector a), Cox7a1 (cytochrome c oxidase
subunit VII a polypeptide 1), and Zic1 (zinc finger protein of the
cerebellum 1), as well as white fat markers (e.g., Hoxc8 [tran-
scription factor homeobox C8]). Due to the high abundance of
mitochondria in BAT, brown fat markers included several mito-
chondrial-targeted proteins that are related to mitochondrial
biogenesis and metabolism (Calvo et al., 2016). Not surprisingly,
our marker core set was enriched in biological processes and
pathways that are known to be involved in energy production
and glucose and lipid metabolism (Figure 3B).
To further evaluate the predicted marker set, we looked for
functional associations between the 59 marker genes (Fig-
ure 3C). We employed a computational method, called iRegulon,
to reverse engineer the transcriptional regulatory network under-
lying our set of differentially expressed marker genes. iRegulon
searches for cis-regulatory regions at 10–20 kb around the tran-
scription start site (TSS) of each gene and then it looks for enrich-
ment in any of 10,000 transcription factor (TF) motifs from
seven different databases and chromatin immunoprecipitation
(ChIP)-seq peaks associated with potential TFs. We identified
four key TFs targeting 39 out of the 59 markers, which were
also differentially expressed between WAT and BAT samples
(log2 fold change > 1.5 and p value < 0.01). Those included
two well-known key adipogenic TFs and co-regulators
described in mammals, which are part of the subfamily of perox-
isome proliferator-activated receptors (Ppara, peroxisome
proliferator-activated receptor alpha; Ppargc1, peroxisome pro-
liferator-activated receptor gamma coactivator 1-alpha; Alvarez-
Dominguez et al., 2015). Another gene, Nr4a1 (nuclear receptor(B) Sample distribution among different adipose tissue types in all microarray an
white adipose tissue; iWAT, inguinal white adipose tissue; mWAT,mesenteric whit
sWAT, subcutaneous white adipose tissue.
(C) Study-by-study principle-component analysis (PCA) of normalized gene expr
See also Table S1 and Figures S1–S4.
3116 Cell Reports 23, 3112–3125, June 5, 2018subfamily 4, group A, member 1; also known as NUR77), was
previously involved in the control of Ucp1 expression (Kanzleiter
et al., 2005). In addition, we identified Gata6, a member of the
GATA factors family. Although those factors are generally
considered as negative regulators of adipogenesis, Gata6 has
not yet been implicated in the regulation of adipogenesis in
mammals (Bou et al., 2017). Next, to validate the predicted
BAT and WAT molecular signatures, we quantified the expres-
sion of eachmarker gene in interscapular BAT and iWAT isolated
from 16-week-old female mice kept at either thermoneutrality or
cold acclimated for two weeks at 18C, followed by 4 weeks at
5C, in order to induce browning (Figure S5). We confirmed
that all of our brown fat markers were indeed highly expressed
in classical BAT from both room temperature and cold-exposed
mice (Figures 3D and S6). The expression of many of those
markers, such as Ucp1, Cidea, Cox7a1, and Pdk4, was also
higher in WAT from cold-exposed mice than in untreated WAT,
reflecting the induction of browning; instead, others appeared
to be brown specific (e.g., Zic1, Impdh1, Tmem246, and
Shmt1). Similar results were obtained with male mice of the
same age and background (data not shown). Notably, several
genes have not yet been associated to BAT (Aco2, Gm13910,
and Acaa2) and WAT (Alcam, Ar, Sgpp1, and Gria3) and could
therefore represent novel BAT and WAT markers.
Automated Prediction of Mouse Adipose Tissue
Browning Capacity
To assess the thermogenic potential of fat tissues in response to
browning agents, we devised a computational model that can
predict brown and white adipocytes content (‘‘BAT probability’’;
probability to be brown-like) independently of sample purity and
experimental systems (Figure 4A). The model combines into a
single-layer neural network (SLNN) the transcriptional profiles
of 51 BAT and 52 WAT samples from M1, M2, M4, M5, M6,
M7, M12, and R4, which represent our ‘‘training set,’’ and the
predicted core marker set. Our choice of SLNN was justified
by a systematic comparison to the performance of other algo-
rithms, such as random forest, naive Bayes, generalized linear
model, recursive partitioning, and support vector machine (Fig-
ure S7). To this goal, each machine learning algorithm was first
trained through a leave-one-out cross-validation (LOOCV)
step, and the accuracy of different models was then assessed
based on the correct classification of BAT and WAT samples
from a ‘‘testing set’’ of nine independent studies (M3, M8, M9,
M10, M11, M13, R1, R2, and R3). As shown in Figure S7,
SLNN outperformed other algorithms and was therefore em-
ployed for follow-up analyses.
Next, we tested the predictive power of our model using tran-
scriptomes of white adipocytes from primary cell culture, whole
fat tissue biopsies, as well as immortalized clonal lines, in which
thermogenesis was activated by either cold, rosiglitazone (RG),
roscovitine (RS), CL316,243 (CL), forskolin, or fexaramine (fex)d RNA-seq studies. eWAT, epididymal white adipose tissue; gWAT, gonadal
e adipose tissue; N/A, not specified; pvWAT, perivascular white adipose tissue;
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treatment (Figures 4B and S8). The model deconvolutes the per-
centage of brown adipocytes (thermogenic cells) and calculates
the probability that a specific sample has acquired a brown-like
transcriptional signature. A browning probability close to 0%and
100% would indicate a fat sample with WAT-like and BAT-like
profiles, respectively. Instead, a browning probability close to
50% would suggest either that the tissue profile is neither
BAT- nor WAT-like (e.g., de-differentiated adipocytes and other
tissue types) or that it has features of both fat types (e.g., it con-
sists of an equal mixture of brown and white adipocytes).
As shown in Figure 4B, our model always classifies BAT and
WAT with almost 100% accuracy and predicts the thermogenic
potential of beige or brite samples to be higher than the corre-
sponding untreated WAT samples, a result that is in agreement
with the relative UCP1 expression level measured in each sam-
ple. A ‘‘positive control’’ in our analysis is represented by study
M9. Here, the model ‘‘misclassifies’’ samples from pvWAT as
having a high browning probability, thus BAT-like. However,
our prediction is fully consistent with findings from the original
study of Fitzgibbons et al. (2011), showing a virtually identical
molecular signature between pvWAT and BAT from mice fed
either a normal or high-fat diet. Notably, cold-treated sWAT
from study M10 showed both a high UCP1 expression level
and browning capacity, whereas the model predicted the same
treatment to be ineffective when applied to mWAT. This result
is consistent with previous observations that rodents’ sWAT de-
pots are more sensitive to acquisition of BAT characteristics and
have a higher thermogenic potential than visceral depots, such
as mWAT (Seale et al., 2011; Tiraby and Langin, 2003). When
we applied our model on datasets from study M13, we found
that samples defined by Wang et al. (2016) to originate from
BAT and iWAT had a browning capacity close to 100% and
0%, respectively. Reassuringly, treatment of iWAT with the
browning agent CL was predicted to yield a strong increase in
browning capacity, in accordance with results from functional
analyses. Similarly, we found that the thermogenic potential of
CL-based iWAT treatment was higher than either RG or RS.
Accordingly, measurements of rectal temperature in mice that
were exposed to cold after treatment with each browning agent
showed that the starting body temperature of CL-treated mice
was the highest and CL was the most potent enhancer of
glucose tolerance among all three drugs. Moreover, HC analysis
also confirmed that, at the transcriptional level, UCP1-positive
adipocytes arising in WAT of mice treated with RG and RS
were more similar to each other than to UCP1-positive cells
from CL-treated mice, which showed a transcriptome very close
to that of BAT. Accordingly, RS- and RG-treated cells expressed
several fold lower levels of Ucp1 than cells from BAT andFigure 3. Prediction and Validation of BAT and WAT Marker Genes
(A) Relative gene expression changes (Z score) for the predicted marker genes
mitochondrial localization of marker genes.
(B) Gene Ontology (GO) and pathway (Reactome) enrichment analysis of marker
(C) Transcriptional regulatory network of BAT andWATmarker genes (circles) and
the log2 fold change of the average expression level in BAT and WAT samples u
(D) Experimental validation of BAT and WAT marker genes (n R 4). On each b
respectively, and the whiskers extend to the most extreme data points.
See also Figures S5 and S6.
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between our predictions and functional characterizations of
fex-treated and untreated iWAT and gWAT from study R2.
Here, the model predicted that fex treatment would not result
in an increased browning activity of WAT. This is in agreement
with the low Ucp1 level measured in those samples and with
observations that fex-treated mice show reduction in weight
gain and improved metabolic homeostasis upon diet-induced
obesity, which was largely attributed to enhanced thermogenic
activity in BAT rather than browning of iWAT or gWAT. However,
the significance of our prediction is difficult to assess for this
study, given that only one replicate for each sample is available.
Overall, our predictions are in agreement with HC analyses,
but whereas those can only provide a qualitative classification
of each sample, our model can also estimate its thermogenic po-
tential in response to a variety of browning stimuli.
Automated Prediction of Human Adipose Tissue
Browning Capacity
To evaluate the applicability of our mouse-based model to de-
convolute browning capacity of heterogeneous adipocyte popu-
lations from human samples, we retrieved publicly available
transcriptomics analyses of human adipose tissues (Table S1;
Figures 5A and S9). Those included a total of 97 datasets from
3 microarray and 2 RNA-seq-based studies on a variety of
different experimental models: immortalized clonal preadipocyte
cell lines derived from stromal vascular fractions (SVFs) of sub-
cutaneous and deep neck of four adult human subjects (study
hM1; Xue et al., 2015); primary adipocytes isolated from paired
biopsies of deep and subcutaneous neck adipose tissue from
six patients undergoing neck surgery (study hM2; Tews et al.,
2014); adipose tissue isolated from abdominal subcutaneous
fat depots of seven type 2 diabetic (T2D) patients before and af-
ter 10 days of cold acclimation (study hM3; Hanssen et al., 2015);
pluripotent stem cell (PSC)-derived white (WAs) and brown (BAs)
adipocytes subjected to the Janus kinase 3 (JAK3) and spleen
tyrosine kinase (SYK) inhibitors tofacitinib and R406, respec-
tively (study hR1; Moisan et al., 2015); and immortalized clonal
brown and white preadipocytes isolated from SVFs in supracla-
vicular BAT and sWAT of two adult humans before and after
in vitro differentiation and in response to forskolin treatment
(study hR2; Shinoda et al., 2015). All of these studies were
used as ‘‘testing set’’ in the neural network model (Figure 5B),
which was trained on BAT and WAT samples from mouse-spe-
cific studies, as previously shown in Figure 4A. Each testing
dataset was first mapped through orthology to mouse genes.
Overall, we observed that the level of UCP1 expression in the
original datasets was not always correlating to the browning(53 and 6 BAT and WAT markers, respectively). MitoCarta2 is used to predict
genes.
predicted targeting transcription factors (squares). Nodes are colored based on
sed for markers prediction (log2 FC > 1.5 and p-adj value < 0.01).
ox, central line and edges represent median and 25th and 75th percentiles,
AB
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capacity predicted by ourmodel. Overall, we foundUCP1 to be a
weak classifier of brown- versus white-like depots, particularly
when analyzing human tissue biopsies. Our observation is in
agreement with previous claims that the thermogenic potential
of human adipose tissues does not directly correlate with the
simple presence of UCP1-positive cells (Rosenwald et al.,
2013). Whereas UCP1 expression can be used as a marker of
active brown adipocytes, in heterogeneous populations, it would
be insufficient to estimate brown adipocyte content. Therefore,
we evaluated the predictive value of our model in human sam-
ples where UCP1 level could not be used to quantify browning.
As an example, Tews et al. (2014) (study hM2) looked for func-
tional differences between paired adipose tissue biopsies from
deep neck, where human BAT is commonly found, and subcu-
taneous neck, where WAT is enriched. Accordingly, our model
predicted higher browning capacity in samples from deep
compared to subcutaneous neck, despite minor changes in
UCP1 expression level measured by microarray analysis. Inter-
estingly, based on our prediction, the deep neck samples of
some patients showed stronger browning capacity than others,
possibly reflecting biological variations in BAT content or tech-
nical differences in the depth of tissue biopsies between individ-
uals. In another study by Hanssen et al. (2015; study hM3),
chronic cold exposure was employed in seven human patients
with T2D as a possible strategy to improve glucose homeostasis.
Cold acclimation was previously shown to increase supraclavic-
ular BAT mass and activity and to lead to recruitment of UCP1-
positive adipocytes in other adipose tissue depots. Accordingly,
all subjects showed an increase in cold-induced glucose uptake
rate in the supraclavicular BAT region, although quite different
between the individuals. However, BAT activity and mass were
unaffected in other fat depots, such as sWAT and visceral
WAT, and no sign of browning could be detected by microar-
ray-based gene expression analysis of abdominal sWAT bi-
opsies from the same patients before and after cold acclimation.
Consistently, we also found that the browning capacity of sWAT
from each patient was unaffected by cold acclimation, given that
there was a minor difference in browning probability between
sWAT samples before and after cold exposure. These results
are in agreement with findings from multiple studies showing
that cold does not brown all human fat depots equally (Conere
et al., 1986; Leitner et al., 2017; Romu et al., 2016; Vosselman
et al., 2014). Findings from our model applied to hR1 datasets
were also in agreement with observations in the original study
by Moisan et al. (2015). Here, the JAK3 and SYK inhibitors, tofa-
citinib and R406, respectively, were shown to induce browning
of human PSC-WAs. When comparing the browning probability
of PSC-WAs samples treated with DMSO, R406, or tofacitinib,
our model correctly predicted a drug-dependent increase inFigure 4. Prediction of Browning Capacity of Mouse Adipose Tissue S
(A) Schematic diagram of the supervised machine learning approach.
(B) Estimation of browning capacity in samples from each test study (right). HC an
shown for all samples and biological replicateswithin each test study (left). The gre
calculated as (sample_Ucp1min_Ucp1)/(max_Ucp1min_Ucp1), where the m
gene expression across test and training sets, respectively. BAT (training set), com
combined WAT samples from all training datasets.
See Table S1 for detailed description of each sample. See also Figures S7 and S
3120 Cell Reports 23, 3112–3125, June 5, 2018browning. We also predicted a much higher browning capacity
for R406 (PSC-WAs SYKi) than for tofacitinib (PSC-WAs
JAK3)-treated adipocytes, which was consistent with evidence
of higher UCP1 and FABP4 (fatty acid binding protein 4) expres-
sion, small lipid droplet area, and mitochondrial content in
response to R406. Our data also suggested that both SYK and
JAK3 inhibitors are more potent browning inducers than cell
fate conversion methods, as shown by comparing the BAT prob-
ability of PSC-derived brown adipocytes (PSC-BAs) with PSC-
WAs. Finally, when testing samples from study hR2, we found
that preadipocytes from supraclavicular and subcutaneous fat
depots showed very low browning capacity, which increased af-
ter differentiation to brown, but not to white adipocytes, respec-
tively. As expected, a cyclic AMP (cAMP) stimulus induced by
treatment with forskolin increased the browning probability of
sWAT-derived clonal lines, also confirmed by the activation of
thermogenic markers observed in Shinoda et al. (2015).
Altogether, these results demonstrate that our mouse-based
model can be also applied to quantify white and brown adipo-
cytes content in ex vivo clonally derived human adipocytes and
complex human biopsies and to reliably predict the thermogenic
potential of treatments applied to induce browning of white fat
depots.
DISCUSSION
Integrative data analyses have been extensively shown to
outperform the predictive power of individual large-scale studies
(Calvo et al., 2006; Liu, 2005; Pagliarini et al., 2008; Perocchi
et al., 2006). Therefore, when combining multiple datasets from
different and complementary approaches, we can learn more
about the system than what would be gained by analyzing
each dataset in isolation. Given the wealthy of transcriptional an-
alyses in the field of adipose biology, obesity, and its comorbid-
ities, we found it timely to perform a meta-analysis of published
data and combine into a single framework the knowledge ac-
quired from each study so far. To this goal, we compiled the
largest adipose-centric gene expression atlas and developed
ProFAT, a systematic and automated approach to derive a
robust and unbiased molecular signature of mouse BAT and
WAT. This was then used to train a computational model in quan-
tifying the browning capacity of heterogeneous fat tissues in
both mouse and humans. We found that BAT and WAT show
clearly distinct molecular signatures, irrespective of the anatom-
ical location of the fat depots, their cell types composition,
experimental models, and procedures employed. Instead,
when we applied ProFAT to several transcriptomics data from
beige samples, we observed that the extent to which beige or
brite fat differs from either WAT or BAT greatly depends onamples from Test Studies by Supervised Machine Learning
alysis based on relative gene expression changes (Z score) of marker genes is
en line on each bar represents the sample’s relativeUcp1 gene expression level
in_Ucp1 andmax_Ucp1 indicate theminimum and themaximum value ofUcp1
bined BAT samples from all training datasets; r, replicates; WAT (training set),
8.
AB
C
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study-to-study differences. Indeed, the degree of browning may
vary due to samples purity, length, and type (cold, PPAR-
gamma, or beta-3 adrenergic receptor agonists) of browning
stimuli and to whether the fat sample derives from tissue bi-
opsies, primary adipocytes, or clonal cell populations. The latter
can be affected by in vitro adaptations, culture microenviron-
ments, and cell-cell interactions. Unsupervised clustering ana-
lyses of gene expression data from pure clonally derived beige
adipocytes have suggested that those could be classified as a
distinct fat type at the transcriptional level (Wu et al., 2012).
Whereas our analysis cannot formally rule out a distinct origin
of beige from either brown or white adipocytes, it prompts for
caution when defining beige-specific signatures in the context
of a few limited dataset and biological models, rather than either
systematically across a large and diverse set of data or based on
pure populations of UCP1-positive cells (Wang et al., 2016).
The computational pipeline developed in this study will be
especially important when trying to evaluate the thermogenic
potential of therapeutic approaches in humans. Human adipose
tissue biopsies usually yield limiting amounts of sample to
perform an exhaustive functional characterization of browning,
and classical BAT markers, like UCP1, have been shown to be
insufficient to predict adipose tissue types. Instead, whole-
genome expression analyses typically require little material to
be performed and have become amethod of choice to infer func-
tional remodeling of WATs, based on the assumption that the
phenotype is reflected in the gene expression signature. Our
meta-analysis enables to classify complex tissue samples from
distinct fat depots as well as from in vitro derived adipocytes
of both mouse and humans, based on their relative brown and
white-like molecular signatures. We envision a scenario in which
medical researchers can directly assess the thermogenic poten-
tial of the patient’s white fat sample, prior to and post-medical
intervention.
Finally, we generate a user-friendly interface where microarray
and RNA-seq-based datasets from mouse and human samples
can be directly uploaded and analyzed with both HC and PCA
methods, and their browning probability can be automatically
computed using ProFAT. This resource can be freely accessed
and should become increasingly powerful with the growing
wealth of transcriptomics data.EXPERIMENTAL PROCEDURES
Systematic Retrieval of Adipose-Tissue-Specific Transcriptional
Profiles
NCBI GEO and EBI ArrayExpress databases published before September 1,
2015 were queried using the following keywords: ‘‘adipocyte,’’ ‘‘adipose
white,’’ ‘‘adipose brown,’’ ‘‘adipose beige,’’ ‘‘fat white,’’ ‘‘fat brown,’’ ‘‘fat
beige,’’ ‘‘BAT,’’ and ‘‘WAT.’’ Systematic retrieval of whole genome expression
profiles for Mus musculus and Homo sapiens from NCBI GEO and EBIFigure 5. Prediction of Browning Capacity of Human Adipose Tissue S
(A) Summary of microarray (hM1–3) and RNA-seq studies (hR1–2) on human fat
(B) Schematic diagram of the supervised machine learning approach.
(C) Estimation of browning capacity (right) and HC analysis (left) of samples
(tofacitinib); PSC-BAs, pluripotent stem cell-derived brown adipocytes; PSC-WA
inhibitor (R406).
See Table S1 for detailed description of each sample. See also Figure S9.
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ities (E-utilities) and programmatic access, respectively. The GEOquery pack-
age fromBioconductor (Davis andMeltzer, 2007) was used to retrieve rawCEL
microarray data. Only microarray and RNA-seq datasets generated with Affy-
metrix and Illumina HiSeq Series sequencing platforms, respectively, were
considered for downstream computational analyses.
Data Processing
Raw CELmicroarray data were normalized by quantile normalization using the
robust multiarray average (RMA) function in affy (Gautier et al., 2004) and oligo
(Carvalho and Irizarry, 2010) R packages. Probe IDs were mapped to Ensembl
gene IDs using Biomart (Durinck et al., 2009) based on the following criteria:
probes not mapping to any gene ID were excluded; probes mapping to multi-
ple gene IDs were assigned to all genes; and for probes mapping to the same
gene ID, the mean expression value was considered.
Processing of raw FastQ files from RNA-seq analyses involved three main
steps. First, adapters, barcodes, and sequences with a Phred quality scores
below 20 were removed using the Trim Galore software. Second, raw reads
were mapped against mouse or human reference genomes (Ensembl release
81) using TopHat v2.0.13 (Trapnell et al., 2009) with Bowtie index (Bow-
tie 2.2.0.0) andGTF transcript annotation files. Next, the number of readsmap-
ping to each Ensembl gene ID were counted using the ht-seq count software
(Anders et al., 2015) to obtain raw read counts and quantify gene expression.
A gene was defined as expressed if the sum of raw read counts across all data-
sets within a studywas >1. Last, DESeq2 (regularized logarithm transformation
algorithm; Love et al., 2014) was used to perform rlog transformation (conver-
sion of raw read counts in log2 scale), which minimizes differences between
samples and normalize with respect to library size.
For each study, a datamatrix was generated, whereby each row and column
corresponded to an Ensembl gene ID and sample ID, respectively. Correlation
analyses were performed using pheatmap R package based on a pairwise dis-
tancematrix generated using Euclidean distance. Biological replicates that did
not replicate were considered as outliers and removed from follow-up ana-
lyses. Data from all microarray or RNA-seq-based studies were aggregated
based on gene IDs and then combat algorithm (Johnson et al., 2007) was
applied to remove the batch effect across multiple batches of microarray
and RNA-seq experiments and to calculate normalized gene expression
values. This algorithm is robust to outliers in small sample sizes and performs
comparable to existing methods for large samples. Hierarchical clustering was
performed using Euclidean distance and complete linkage based on normal-
ized gene expression values. Differential gene expression analysis was per-
formed using the Limma algorithm, and significantly differentially expressed
genes were defined based on an adjusted p values < 0.01 and a mean log2
fold-change threshold >1.5.
Identification of BAT and WAT Marker Genes
Microarray and RNA-seq gene expression data on BAT and WAT samples
from the following studies M1, M2, M4, M5, M6, M7, M12, and R4 were com-
bined based on Gene IDs. Combat algorithm (Johnson et al., 2007) was
applied to remove batch effects and to calculate normalized gene expression
values. Next, the MGFM (Marker Gene Finder in MicroArray) bioinformatics
tool (El Amrani et al., 2015) was applied to predict genes that allow a robust
and specific segregation of samples from BAT and WAT types (http://www.
bioconductor.org/packages/release/bioc/html/MGFM.html; default parame-
ters). The subset of 59 genes that were significantly differentially expressed
(log2 fold-change > 1.5 and p-adj value < 0.01) was selected as a core BAT
and WAT marker set. The ConcensusPathDB-Mouse (http://cpdb.molgen.
mpg.de/MCPDB) was used to identify non-redundant functional categoriesamples by Supervised Machine Learning
samples.
from each human-adipocytes-based study. JAK3i, Janus kinase 3 inhibitor
s, pluripotent stem cell derived white adipocytes; SYKi, spleen tyrosine kinase
from Gene Ontology (GO) and Reactome that were enriched within BAT and
WAT marker genes (p value < 0.01). Cytoscape (Shannon et al., 2003) was
used to display the predicted regulatory network.
In-House RNA-Seq
Total RNA was extracted from inguinal WAT and interscapular BAT of
16-week-old female C57BL/6 mice kept either for the whole life at an ambient
temperature of 30C or for two weeks at 18C followed by 4 weeks at 5C
(n = 4; not randomization and blinding applied). Qiazol was used for RNA
extraction according to the manufacturer’s instructions (Qiazol Lysis Reagent;
QIAGEN). The quality of the RNA was determined with the Agilent 2100
BioAnalyzer (RNA 6000 Nano Kit; Agilent Technologies). All samples had a
RNA integrity number (RIN) value greater than 8. For library preparation, 1 mg
of total RNA per sample was used. RNAmolecules were poly(A) selected, frag-
mented, and reverse transcribed with the Elute, Prime, Fragment Mix (EPF;
Illumina). End repair, A-tailing, adaptor ligation, and library enrichment were
performed as described in the low-throughput protocol of the TruSeq RNA
Sample Prep Guide (Illumina). RNA libraries were assessed for quality and
quantity with the Agilent 2100 BioAnalyzer and the Quant-iT PicoGreen dsDNA
Assay Kit (Life Technologies). RNA libraries were sequenced as 100-bp paired-
end runs on an Illumina HiSeq2500 platform. The animal welfare authorities
approved animal maintenance and experimental procedures.
Prediction of Adipose Tissue Browning Capacity by Machine
Learning
A neural network model was developed with one hidden layer, using caret
R package with method set to nnet. Leave-one-out cross validation was
used to tune the number of hidden units and weight decay, whereas default
values were used for the remaining parameters. Datasets were exclusively as-
signed to either a test or a training group. The training data only included data-
sets from study M1, M2, M4, M5, M6, M7, M12, and R4. Instead, the test data
included microarray and RNA-seq datasets from study M3, M8, M9, M10,
M11, M13, R1, R2, and R3. To avoid introducing circularity in the analysis,
test datawere independent from training data andwere never used for training.
COMBAT algorithm was applied to normalize any new test dataset against the
training set in order to remove batch effects, and then the training set together
with the core marker set were used in the neural network. Human transcrip-
tional profiles were also used as testing set by mapping human gene IDs to
mouse ortholog gene IDs with BioMart (Ensembl release 81) restricted to
ortholog_one2one mapping type.
Statistical Analysis
Z score is calculated as (X  m)/s, where X is the value of the element, m is the
mean, and s is the SD. A marker gene is defined significant if the adjusted
p value < 0.01 and the log2(fold change) > 1.5, where p value and fold change
are calculated with DESeq R package.
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The accession number for in-house RNA-seq data reported in this paper is
GEO: GSE112582. The data and code can be accessed at https://github.
com/PerocchiLab/ProFAT. Accession codes for publicly available microarray
and RNA-seq datasets used in this study are also listed in Table S1.
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